Repeated liver resections for recurrent intrahepatic cholangiocarcinoma

Polyakov AN, Patyutko YuI, Chistyakova OV, et al. . Repeated liver resections for recurrent intrahepatic cholangiocarcinoma. Pirogov Russian Journal of Surgery. 2024;(9):30‑37. (In Russ., In Engl.)
https://doi.org/10.17116/hirurgia202409130

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Abstract:

OBJECTIVE

To evaluate the safety and advisability of repeated liver resection (RLR) for recurrent intrahepatic cholangiocarcinoma (ICC).

MATERIAL AND METHODS

The results of RLR for ICC recurrence (n=10) were retrospectively analyzed between 1999 and 2023. The control group consisted of patients undergoing primary liver resection for ICC (n=195).

RESULTS

Surgery time (p=0.001) and blood loss (p=0.038) were lower in the RLR group. There were no blood transfusions (0 vs. 31.8%, p=0.034) and 90-day mortality (0 vs. 3.2%, p=1.0) in the same group. The risk of complications (30.0% vs.45.6%, p=0.517) and adverse events grade ≥ III (20.0% vs. 17.9%, p=1.0) was similar in both groups. Multifocal intrahepatic nodes were more common in the RLR group (60% vs. 37.9%, p=0.193), while there were no negative factors such as lymph nodes involvement (0 vs. 34.4%, p=0.032) and invasion of surrounding structures (0 vs. 38.5%, p=0.015). Dimensions of the largest node were smaller in repeated resection (2 vs. 8 cm, p<0.0001). Incidence of R0 resections (80.0% vs. 82.1%, p=1.0) was comparable. Long-term results were similar: five-year overall survival 17.2% and 34.7% (p=0.912), three-year disease-free survival 20.0% and 26.5% (p=0.421).

CONCLUSION

Similar results of repeated and primary liver resections confirm advisability of RLR for intrahepatic recurrence of ICC.

Keywords:

cholangiocarcinoma

intrahepatic bile duct cancer

intrahepatic recurrence

redo resection

Authors:

Polyakov A.N.

Blokhin National Medical Research Center of Oncology

SPIN RSCI: 9924-0256
Scopus AuthorID: 57190413973
ORCID: 0000-0001-5348-5011

Patyutko Yu.I.

Blokhin National Medical Research Center of Oncology

RSCI AuthorID: 137980
Scopus AuthorID: 55666204300
ORCID: 0000-0001-9254-1346

Chistyakova O.V.

Blokhin National Cancer Research Center

ORCID: 0000-0002-2958-2855

Kotelnikov A.G.

Blokhin National Medical Cancer Research Center

ORCID: 0000-0002-2811-0549

Sergeeva O.N.

Blokhin National Cancer Research Center

SPIN RSCI: 5427-7357
ORCID: 0000-0003-1932-5983

Umirzokov A.Sh.

Blokhin National Cancer Research Center

ORCID: 0000-0001-9126-3153

Shishkina N.A.

Blokhin National Cancer Research Center

ORCID: 0000-0002-5037-9085

Podluzhnyi D.V.

Blokhin National Medical Cancer Research Center

ORCID: 0000-0001-7375-3378

Received:

05.03.2024

Accepted:

28.03.2024

Close metadata

References:

Wu L, Tsilimigras DI, Paredes AZ, Mehta R, Hyer JM, Merath K, Sahara K, Bagante F, Beal EW, Shen F, Pawlik TM. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival. World Journal of Surgery. 2019;43(7):1777-1787. https://doi.org/10.1007/s00268-019-04966-4
Kupietzky A, Ariche A. Surgical Aspects of Intrahepatic Cholangiocarcinoma. Cancers. 2022;14(24):6265. https://doi.org/10.3390/cancers14246265
Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. Journal of Hepatology. 2020;72(2):364-377. https://doi.org/10.1016/j.jhep.2019.11.020
Si A, Li J, Yang Z, Xia Y, Yang T, Lei Z, Cheng Z, Pawlik TM, Lau WY, Shen F. Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 2019;26(6):1841-1850. https://doi.org/10.1245/s10434-019-07260-8
Orcutt ST, Anaya DA. Liver Resection and Surgical Strategies for Management of Primary Liver Cancer. Cancer Control. 2018;25(1):1073274817744621. https://doi.org/10.1177/1073274817744621
El-Diwany R, Pawlik TM, Ejaz A. Intrahepatic Cholangiocarcinoma. Surgical Oncology Clinics of North America. 2019;28(4):587-599.
Kang SH, Choi Y, Lee W, Ahn S, Cho JY, Yoon YS, Han HS. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching. Surgical Oncology. 2020;33:63-69. https://doi.org/10.1016/j.suronc.2020.01.001
Doussot A, Gonen M, Wiggers JK, Groot-Koerkamp B, DeMatteo RP, Fuks D, Allen PJ, Farges O, Kingham TP, Regimbeau JM, D’Angelica MI, Azoulay D, Jarnagin WR. Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. Journal of the American College of Surgeons. 2016;223(3):493-505.e2. https://doi.org/10.1016/j.jamcollsurg.2016.05.019
Ramouz A, Ali-Hasan-Al-Saegh S, Shafiei S, Fakour S, Khajeh E, Majlesara A, Adeliansedehi A, Probst P, Springfeld C, Chang DH, Rupp C, Carvalho C, Golriz M, Hoffmann K, Mehrabi A. Repeat liver resection for recurrent intrahepatic cholangiocarcinoma: meta-analysis. British Journal of Surgery. 2022;109(7):580-587. https://doi.org/10.1093/bjs/znac075
Mabilia A, Mazzotta AD, Robin F, Ghallab M, Vibert E, Adam R, Cherqui D, Cunha AS, Azoulay D, Salloum C, Pittau G, Ciacio O, Allard MA, Boudjema K, Sulpice L, Golse N. R1 Vascular or Parenchymal Margins: What Is the Impact after Resection of Intrahepatic Cholangiocarcinoma? Cancers. 2022;14(20):5151. https://doi.org/10.3390/cancers14205151
Spolverato G, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Clark Gamblin T, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Tran TB, Wallis Marsh J, Pawlik TM. Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Annals of Surgical Oncology. 2016;23(1):235-243. https://doi.org/10.1245/s10434-015-4642-9
Kojima T, Umeda Y, Fuji T, Niguma T, Sato D, Endo Y, Sui K, Inagaki M, Oishi M, Ota T, Hioki K, Matsuda T, Aoki H, Hirai R, Kimura M, Yagi T, Fujiwara T. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery. PLoS One. 2020;15(9):e0238392. https://doi.org/10.1371/journal.pone.0238392
Park HM, Yun SP, Lee EC, Lee SD, Han SS, Kim SH, Park SJ. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery. Annals of Surgical Oncology. 2016;23(13):4392-4400. https://doi.org/10.1245/s10434-016-5454-2
Edeline J, Lamarca A, McNamara MG, Jacobs T, Hubner RA, Palmer D, Groot Koerkamp B, Johnson P, Guiu B, Valle JW. Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. Cancer Treatment Reviews. 2021;99:102258. https://doi.org/10.1016/j.ctrv.2021.102258
Kaibori M, Ichihara N, Miyata H, Kakeji Y, Nanashima A, Kitagawa Y, Yamaue H, Yamamoto M, Endo I. Surgical outcomes of laparoscopic versus open repeat liver resection for liver cancers: A report from a nationwide surgical database in Japan. Journal of Hepato-biliary-Pancreatic Sciences. 2022;29(8):833-842. https://doi.org/10.1002/jhbp.1156
Alaimo L, Moazzam Z, Brown ZJ, Endo Y, Ruzzenente A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Endo I, Pawlik TM. Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence. Annals of Surgical Oncology. 2023;30(3):1340-1349. https://doi.org/10.1245/s10434-022-12463-7
Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Pawlik TM. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. British Journal of Surgery. 2018;105(7):848-856. https://doi.org/10.1002/bjs.10676
Tsilimigras DI, Sahara K, Wu L, Moris D, Bagante F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Moro A, Sasaki K, Aucejo F, Zhang XF, Matsuyama R, Endo I, Pawlik TM. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. JAMA Surgery. 2020;155(9):823-831. https://doi.org/10.1001/jamasurg.2020.1973
Hu LS, Zhang XF, Weiss M, Popescu I, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Itaru E, Pawlik TM. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 2019;26(8):2549-2557. https://doi.org/10.1245/s10434-019-07353-4
Bartsch F, Eberhard J, Rückert F, Schmelzle M, Lehwald-Tywuschik N, Fichtner-Feigl S, Gaedcke J, Oldhafer KJ, Oldhafer F, Diener M, Mehrabi A, Settmacher U, Becker T, Keck T, Friess H, Strücker B, Opitz S, Lemke J, Schnitzbauer A, Lang H; German ICC Collaboration Group. Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study. Liver International. 2021;41(1):180-191. https://doi.org/10.1111/liv.14682
Bekki Y, Von Ahrens D, Takahashi H, Schwartz M, Gunasekaran, G. Recurrent Intrahepatic Cholangiocarcinoma - Review. Frontiers in Oncology. 2021;11:776863. https://doi.org/10.3389/fonc.2021.776863
Li Q, Chen C, Su J, Qiu Y, Wu H, Song T, Mao X, He Y, Cheng Z, Li J, Zhai W, Zhang D, Geng Z, Tang Z. Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study. BMC Cancer. 2022;22(1):329. https://doi.org/10.1186/s12885-022-09448-w
Pechetov AA, Zhao AV, Ragimov ShV, Volchansky DA, Makov MA, Gurmikov BN. Thoracoscopic metastasectomy is the method of choice in the stepwise treatment of disseminated cholangiocellular carcinoma. P.A. Herzen Journal of Oncology. 2021;10(2):39-43. (In Russ.). https://doi.org/10.17116/onkolog20211002139
Fernández L, Gastaca M, Alonso E, Prieto M, Ruiz P, Ventoso A, Palomares I, Perfecto A, Valdivieso A. Surgical treatment for recurrent cholangiocarcinoma: a single-center series. Frontiers in Oncology. 2023;13:1169133. https://doi.org/10.3389/fonc.2023.1169133
Xu C, Li L, Xu W, Du C, Yang L, Tong J, Yi Y. Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results. International Journal of Hyperthermia. 2019;36(1):351-358. https://doi.org/10.1080/02656736.2019.1571247
Moskalenko AN, Lyadov VK, Sagaydak IV, Chernykh M V, Britskaya N N. Stereotactic body radiation therapy in patients with liver oligometastases from colorectal cancer: a systematic review. Pelvic Surgery and Oncology. 2021;12(1):49-57. (In Russ.). https://doi.org/10.17650/2686-9594-2022-12-1-49-57
Zhang XX, Ma HB, Li TH, Huang B, Jia NY, Meng Y. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma. Clinical and Translational Oncology. 2023;25(3):731-738. https://doi.org/10.1007/s12094-022-02979-5
Lee J, Yoon WS, Koom WS, Rim CH. Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review. Wirksamkeit der stereotaktischen Strahlentherapie bei nichtresektablem oder rezidivierendem Cholangiokarzinom: eine Metaanalyse und systematische Übersicht. Strahlentherapie und Onkologie. 2019;195(2):93-102. https://doi.org/10.1007/s00066-018-1367-2